Canopy Studies Senior Care Cannabis
Canopy Growth’s subsidiary, Spectrum Cannabis, will partner with Ontario Long Term Care Association (OLTCA) to develop a medical cannabis pilot study and care pathway for long-term care patients in LTC homes in Ontario.
The Smith Falls, Ontario-based cannabis producer Canopy Growth (TSX: WEED) (NYSE: CGC) said the six-month study will measure how medical cannabis might displace less-desirable therapeutics for pain and cognitive function.
The study will be coordinated by the OLTCA, with Spectrum providing product. This will be one of the world’s first and largest cannabis programs in the long-term care area, with up to 500 participants.
“The pilot study…is the first step in developing an evidence-based…approach to medical cannabis…for seniors and ultimately improve quality of life…in long-term care homes,” ” said Mark Zekulin, President & Co-CEO, Canopy Growth.
Spectrum aims to simplify medical cannabis for patients and practitioners. Founded in Canada, it operates in Australia, South America, Africa and across Europe. Spectrum’s products include whole flower cannabis, oils and Softgels.
Canopy Growth is a leading diversified cannabis company with over a dozen licensed production sites globally, and over 3.2 million sf of production capacity. It operates in 11 countries on five continents. Canopy has partnerships with Snoop Dogg, breeding firms DNA Genetics and Green House seeds, and Fortune 500 alcohol company Constellation Brands.
The Ontario Long Term Care Association is the largest association of long-term care providers in Canada, representing private, not-for-profit, charitable, and municipal providers. It represents nearly 70% of Ontario’s 630 long-term care homes, and serves over 70,000 residents annually.
Source Canopy press release
{{cta(‘b491434f-c6aa-4547-b3d4-6a7293c8ad67’)}}
About Cannin Investment Group: Your Pot Stocks Experts
Cannin is your trusted resource for pot stocks. Our global team of experts evaluates all emerging pot stock investing opportunities. We aggregate hundreds of hours of research and provide tips on the best pot stock investments for 2020.
Use Cannin as your resource for:
- Cannabis and hemp investing news
- Featured cannabis and hemp company analysis
- Comprehensive cannabis and hemp stock reports
Is it too late to invest in pot stocks? No! This is the perfect time to invest.
Market analysts expect the legal cannabis industry will have an annual value exceeding $75 Billion in the next decade. The time to invest in pot stocks is now. Are you looking to buy stock in pot companies for 2020? Interested in emerging penny pot stocks? Looking for the best Canadian pot stocks to invest in? We can help.
Are you interested in pot stocks like Curaleaf, Trulieve, Aurora Cannabis, or Canopy Growth?
Predict price movements of pot stocks several hours in advance with our proprietary algorithmic stock trading software.
- +25% Gains in 2020
- +49.8% Gains in 2019
- 108% Backtested since 2012
We’re so confident you’ll love our algotrading pot stock signals, we’re willing to give you a one-month risk-free trial to see it for yourself.
Profit from the best pot stocks – we’ll show you how at cannin.com.
Marijuana Stocks, Pot Stocks, Algorithmic Stock Trading, Penny Hemp Stocks
